Aandeel 9776 SAPPORO CLINICAL LABORATORY INC.
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren

Andere talen Sapporo Clinical Laboratory Inc.

Aandelen

9776

JP3321100004

Vertraagde tijd Japan Exchange
Andere beurzen
 03:08:07 07-05-2024 		Variatie 5 dagen Verschil t.o.v. 1 jan (%)
1.104 JPY +0,36% Intraday-grafiek van Sapporo Clinical Laboratory Inc. +2,60% +10,29%
26/02 Sapporo Clinical Laboratory Inc. (TSE:9776) kondigt een aandeleninkoopprogramma aan voor 232.100 aandelen, die 6,97% vertegenwoordigen voor ¥ 209,12 miljoen. CI
26/02 Sapporo Clinical Laboratory Inc. autoriseert een terugkoopplan. CI

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
Tranche Update on Sapporo Clinical Laboratory Inc.'s Equity Buyback Plan announced on February 26, 2024.
Sapporo Clinical Laboratory Inc.'s Equity Buyback announced on March 26, 2024, has closed with 210,800 shares, representing 6.33% for ¥189.93 million.
Sapporo Clinical Laboratory Inc. announces an Equity Buyback for 232,100 shares, representing 6.97% for ¥209.12 million.
Sapporo Clinical Laboratory Inc. authorizes a Buyback Plan.
Sapporo Clinical Laboratory Inc. Reports Earnings Results for the Full Year Ended March 31, 2023
Tranche Update on Sapporo Clinical Laboratory Inc.'s Equity Buyback Plan announced on May 30, 2022.
Sapporo Clinical Laboratory Inc.'s Equity Buyback announced on May 30, 2022 has closed with 22,700 shares, representing 0.67% for ¥29.21 million.
Sapporo Clinical Laboratory Inc. announces an Equity Buyback for 22,700 shares, representing 0.68% for ¥29.21 million.
Sapporo Clinical Laboratory Inc. authorizes a Buyback Plan.
Tranche Update on Sapporo Clinical Laboratory Inc.'s Equity Buyback Plan announced on February 28, 2022.
Sapporo Clinical Laboratory Inc.'s Equity Buyback announced on February 28, 2022, has closed with 53,700 shares, representing 1.58% for ¥69.11 million.
Sapporo Clinical Laboratory Inc. announces an Equity Buyback for 53,700 shares, representing 1.58% for ¥69.11 million.
Sapporo Clinical Laboratory Inc. authorizes a Buyback Plan.
Tranche Update on Sapporo Clinical Laboratory Inc.'s Equity Buyback Plan announced on June 21, 2021.
Sapporo Clinical Laboratory Inc.'s Equity Buyback announced on June 21, 2021, has closed with 16,300 shares, representing 0.48% for ¥25.92 million.
Sapporo Clinical Laboratory Inc. announces an Equity Buyback for 16,300 shares, representing 0.48% for ¥25.92 million.
Sapporo Clinical Laboratory Inc. authorizes a Buyback Plan.
Tranche Update on Sapporo Clinical Laboratory Inc.'s Equity Buyback Plan announced on June 26, 2018.
Sapporo Clinical Laboratory Inc.'s Equity Buyback announced on June 26, 2018 has expired with 39,200 shares, representing 1.13% for ¥96 million.
Sapporo Clinical Laboratory Inc. announces an Equity Buyback for 45,000 shares, representing 1.3% for ¥110.21 million.
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers 9776
  4. Nieuws Sapporo Clinical Laboratory Inc.
  5. Andere talen